title: Neglected diseases, delinquent diagnostics.
authors.affiliation: Mark Kessel is chairman of the Foundation for Innovative New Diagnostics (FIND), 1202 Geneva, Switzerland; of counsel to Shearman & Sterling LLP, New York, NY 10022, USA; and a partner of Symphony Capital, New York, NY 10022, USA. mark.kessel@shearman.com.
authors.forename: Mark
authors.initials: M
authors.lastname: Kessel
mesh_terms: D003140:Communicable Disease Control; D014943:Global Health; D006801:Humans; D008288:Malaria / Q000175:diagnosis / Q000628:therapy; D058069:Neglected Diseases / Q000175:diagnosis* / Q000628:therapy*; D057170:Translational Research, Biomedical / Q000639:trends*; D014353:Trypanosomiasis, African / Q000175:diagnosis / Q000628:therapy; D014376:Tuberculosis / Q000175:diagnosis / Q000628:therapy; D014481:United States; D014944:World Health Organization